183 related articles for article (PubMed ID: 9246715)
1. Hemodynamic studies and esophageal morphometric analyses in portal hypertensive rats with left adrenal vein ligation.
Lee FY; Wang SS; Tsai YT; Chang FY; Lin HC; Hou MC; Chu CJ; Wu SL; Tai CC; Lee SD
Scand J Gastroenterol; 1997 Jul; 32(7):725-30. PubMed ID: 9246715
[TBL] [Abstract][Full Text] [Related]
2. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
[TBL] [Abstract][Full Text] [Related]
3. A rat model of esophageal varices.
Tanoue K; Kitano S; Hashizume M; Wada H; Sugimachi K
Hepatology; 1991 Feb; 13(2):353-8. PubMed ID: 1995442
[TBL] [Abstract][Full Text] [Related]
4. Expression of TNF-alpha and VEGF in the esophagus of portal hypertensive rats.
Yin ZH; Liu XY; Huang RL; Ren SP
World J Gastroenterol; 2005 Feb; 11(8):1232-6. PubMed ID: 15754412
[TBL] [Abstract][Full Text] [Related]
5. Early propranolol administration does not prevent development of esophageal varices in cirrhotic rats.
Alatsakis M; Ballas KD; Pavlidis TE; Psarras K; Rafailidis S; Tzioufa-Asimakopoulou V; Marakis GN; Sakantamis AK
Eur Surg Res; 2009; 42(1):11-6. PubMed ID: 18971580
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats.
Lopez-Talavera JC; Merrill WW; Groszmann RJ
Gastroenterology; 1995 Mar; 108(3):761-7. PubMed ID: 7875478
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
8. Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Wu SL; Chan CC; Tai CC; Lai IN; Lee SD
J Hepatol; 1999 Jun; 30(6):1105-11. PubMed ID: 10406190
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
[TBL] [Abstract][Full Text] [Related]
10. Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor-alpha.
Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Wu SL; Tai CC; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):145-50. PubMed ID: 9198288
[TBL] [Abstract][Full Text] [Related]
11. Change in vascular cAMP and cGMP contents in portal hypertensive rats.
Huang YT; Lo JW; Lin HC; Tsai YT; Hong CY; Yang MC
Pharmacology; 1995 Feb; 50(2):86-91. PubMed ID: 7536331
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of chronic tetramethylpyrazine administration on portal hypertensive rats.
Chang FC; Huang YT; Hong CY; Lin JG; Chen KJ
Eur J Gastroenterol Hepatol; 1999 Sep; 11(9):1027-31. PubMed ID: 10503841
[TBL] [Abstract][Full Text] [Related]
13. Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension.
Genecin P; Polio J; Groszmann RJ
Am J Physiol; 1990 Sep; 259(3 Pt 1):G498-503. PubMed ID: 2399990
[TBL] [Abstract][Full Text] [Related]
14. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
Wang CT; Kuang YL; Chen ZP
Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
[TBL] [Abstract][Full Text] [Related]
15. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of propranolol improves vascular contractile responsiveness in portal hypertensive rats.
Huang YT; Lin HC; Tsai JF; Hou MC; Hong CY
Eur J Clin Invest; 1997 Jul; 27(7):550-5. PubMed ID: 9263740
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
[TBL] [Abstract][Full Text] [Related]
18. A rat model of liver cirrhosis and esophageal varices.
Sakadamis AK; Ballas KD; Tzioufa-Asimakopoulou V; Alatsakis MB
Res Exp Med (Berl); 2001 Mar; 200(3):137-54. PubMed ID: 11426666
[TBL] [Abstract][Full Text] [Related]
19. Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.
Chang CC; Wang SS; Huang HC; Lee JY; Lee FY; Lin HC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1394-400. PubMed ID: 20659229
[TBL] [Abstract][Full Text] [Related]
20. Portal hypertension ameliorates arterial hypertension in spontaneously hypertensive rats.
Polio J; Groszmann RJ; Reuben A; Sterzel RB; Better OS
J Hepatol; 1989 May; 8(3):294-301. PubMed ID: 2732443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]